Clinical trial
Extent of Internal Limiting Membrane Removal and Its Impact on Outcomes of Macular Hole Surgery
NCT02010138 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extent of Internal Limiting Membrane Removal and Its Impact on Outcomes of Macular Hole Surgery
- Lead sponsor
- Samsung Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- November 30, 2015
- Enrollment
- 65 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
macular holes